SS
CCEL icon

SBI Securities’s Cryo-Cell International CCEL Stock Holding History

SBI Securities’s Portfolio CCEL Stock Details CCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2
Closed -$9 – 4060
2025
Q3 		$9 Hold
2
– – ﹤0.01% 4040
2025
Q2 		$10 Sell
2
-250
-99% -$1.32K ﹤0.01% 4007
2025
Q1 		$1.6K Buy
252
+147
+140% +$1.07K ﹤0.01% 2385
2024
Q4 		$778 Buy
+105
New +$792 ﹤0.01% 2724

Other funds holding CCEL

HLA
Hamilton Lane Advisors Conshohocken, Pennsylvania $149M AUM 14.17% 1-Year Est. Return
SA
SFI Advisors Montclair, New Jersey $95.2M AUM 23.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

SBI Securities's CCEL Position: Q4 2025 in Review

SBI Securities sold out of Cryo-Cell International (CCEL) in Q4 2025, closing a stake of 2 shares — an estimated $9 sold.

SBI Securities first reported a position in CCEL in Q4 2024 and held it in 4 quarters. The position peaked at $1.6K in Q1 2025. 17 funds tracked by Wall St. Rank hold CCEL as of Q4 2025.

  • SBI Securities reported no remaining Cryo-Cell International position as of Q4 2025 after selling out during the quarter.
  • SBI Securities sold 2 Cryo-Cell International shares in Q4 2025, an estimated $9.
  • SBI Securities first reported a position in Cryo-Cell International in Q4 2024 and held it in 4 quarters.
  • SBI Securities's Cryo-Cell International position peaked at $1.6K in Q1 2025.
  • 17 funds tracked by Wall St. Rank held Cryo-Cell International as of Q4 2025.

Based on SBI Securities's 13F filing for Q4 2025, filed 3 Feb 2026.